respiratory:start
This is an old revision of the document!
Respiratory Pharmacology
pharmacology respiratory
Respiratory pharmacology focuses on airway tone, inflammation, and mucus—the 3 big levers we manipulate in asthma/COPD and related conditions.
Some respiratory diseases instead involve alveolar injury and fibrosis, which require completely different therapy (antifibrotics & immunosuppression).
Quick Navigation
Obstructive Lung Disease (Core)
Bronchodilators
Interstitial Lung Disease
Anti-Inflammatory Controllers
Pulmonary Fibrosis Therapy
Other Respiratory Topics
Drug Classes
β2-Agonists (Bronchodilators)
Antimuscarinics (Bronchodilators)
Inhaled Corticosteroids (Controllers)
Leukotriene Pathway
Biologics for Severe Asthma
Antifibrotics (Pulmonary Fibrosis)
Immune-Mediated ILD Therapy
Cough & Mucus
Smoking Cessation
High-Yield Tables
| Condition | First-Line Core | Add-Ons | Notes |
|---|---|---|---|
| Asthma | ICS (or ICS-formoterol strategy) | LABA, LAMA, LTRA, biologics | LABA never alone in asthma |
| COPD | LAMA or LABA | LAMA/LABA, +/- ICS | ICS helps mainly with frequent exacerbations/eosinophils |
| Pulmonary Fibrosis | Antifibrotic | Oxygen, transplant eval | Slows decline — does NOT reverse disease |
| Acute bronchospasm | SABA | SAMA (esp COPD), systemic steroids | Think trigger + oxygenation |
Build-Out Checklist (for you)
- Create master pages: SABA/LABA, SAMA/LAMA, ICS, LTRA/5-LO, Biologics, Antifibrotics
- Add step therapy quick guides (Asthma & COPD) with 1-page algorithms
- Add device technique page (MDI vs DPI vs neb) + spacer pearls
- Add ILD pattern recognition quick guide (UIP vs NSIP vs HP)
Key Distinction: Bronchodilators treat airway narrowing — antifibrotics treat lung scarring.
respiratory/start.1771165242.txt.gz · Last modified: by andrew2393cns